{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:46:27Z","timestamp":1794329187918,"version":"4.9.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biopha.2025.118496","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T19:32:33Z","timestamp":1756755153000},"page":"118496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Carotenoids as neuroprotective agents in multiple sclerosis: Pathways, mechanisms, and clinical prospects"],"prefix":"10.1016","volume":"191","author":[{"given":"Elham","family":"Nadimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Jamal Omidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshad","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hashem","family":"Hashempur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Iraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118496_bib1","doi-asserted-by":"crossref","unstructured":"Coles A. Alastair Compston, Alasdair Coles. Lancet. 2008;372:1502-1517.","DOI":"10.1016\/S0140-6736(08)61620-7"},{"issue":"1","key":"10.1016\/j.biopha.2025.118496_bib2","article-title":"Neurodegeneration in multiple sclerosis","volume":"15","author":"Mey","year":"2023","journal-title":"WIREs Mech. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118496_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jpp\/rgad107","article-title":"Dysregulation of tyrosinase activity: a potential link between skin disorders and neurodegeneration","volume":"76","author":"Jin","year":"2024","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118496_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1448377","article-title":"Global burden of multiple sclerosis and its attributable risk factors, 1990\u20132019","volume":"15","author":"Safiri","year":"2024","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118496_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis\u2013a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur. J. Neurol."},{"issue":"15","key":"10.1016\/j.biopha.2025.118496_bib6","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1096\/fasebj.9.15.8529834","article-title":"Structure and properties of carotenoids in relation to function","volume":"9","author":"Britton","year":"1995","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2025.118496_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153676","article-title":"The neuroprotective potential of carotenoids in vitro and in vivo","volume":"91","author":"Manochkumar","year":"2021","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.biopha.2025.118496_bib8","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1007\/s00210-024-03520-x","article-title":"Lycopene in Male infertility","volume":"398","author":"Vakili","year":"2025","journal-title":"NaunynSchmiede 's. Arch. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118496_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.algal.2023.103372","article-title":"An overview of potential algae-derived bioactive compounds against urease-positive microorganisms","volume":"77","author":"Oliyaei","year":"2024","journal-title":"Algal Res."},{"issue":"11","key":"10.1016\/j.biopha.2025.118496_bib10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.nutres.2014.07.010","article-title":"Carotenoids, inflammation, and oxidative stress\u2014implications of cellular signaling pathways and relation to chronic disease prevention","volume":"34","author":"Kaulmann","year":"2014","journal-title":"Nutr. Res."},{"issue":"8","key":"10.1016\/j.biopha.2025.118496_bib11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3390\/antiox9080706","article-title":"Lycopene as a natural antioxidant used to prevent human health disorders","volume":"9","author":"Imran","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2025.118496_bib12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ejmech.2019.06.010","article-title":"Medicinal prospects of antioxidants: a review","volume":"178","author":"Neha","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118496_bib13","first-page":"1","article-title":"Biological activities of astaxanthin in the treatment of neurodegenerative diseases","author":"Lotfi","year":"2024","journal-title":"Neurodegener. Dis. Manag."},{"issue":"1","key":"10.1016\/j.biopha.2025.118496_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/ars.2016.6958","article-title":"Essential dietary bioactive lipids in neuroinflammatory diseases","volume":"29","author":"Catani","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.biopha.2025.118496_bib15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.lfs.2016.05.021","article-title":"Lycopene ameliorates neuropathic pain by upregulating spinal astrocytic connexin 43 expression","volume":"155","author":"Zhang","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2025.118496_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.meatsci.2016.04.005","article-title":"Natural antioxidants as food and feed additives to promote health benefits and quality of meat products: a review","volume":"120","author":"Jiang","year":"2016","journal-title":"Meat Sci."},{"key":"10.1016\/j.biopha.2025.118496_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-319-47861-6_7","article-title":"Role of oligodendrocyte dysfunction in demyelination, remyelination and neurodegeneration in multiple sclerosis","author":"Dulamea","year":"2017","journal-title":"Mult. Scler. Bench Bedside. Glob. Perspect. a Silent Kill."},{"issue":"16","key":"10.1016\/j.biopha.2025.118496_bib18","doi-asserted-by":"crossref","first-page":"12631","DOI":"10.3390\/ijms241612631","article-title":"Smouldering lesion in MS: microglia, lymphocytes and pathobiochemical mechanisms","volume":"24","author":"Pukoli","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118496_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2025.118496_bib20","series-title":"Ocular Manifestations of Systemic Diseases","first-page":"375","article-title":"Neurological disorders","author":"Kasl","year":"2024"},{"issue":"2","key":"10.1016\/j.biopha.2025.118496_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ncl.2010.12.009","article-title":"The immunopathophysiology of multiple sclerosis","volume":"29","author":"Wu","year":"2011","journal-title":"Neurol. Clin."},{"issue":"12","key":"10.1016\/j.biopha.2025.118496_bib22","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","article-title":"The immunology of multiple sclerosis","volume":"22","author":"Attfield","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.118496_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/B978-0-444-52001-2.00004-2","article-title":"Demyelination in multiple sclerosis","volume":"122","author":"Lubetzki","year":"2014","journal-title":"Handb. Clin. Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118496_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/msj.20246","article-title":"Axonal damage in multiple sclerosis","volume":"78","author":"Haines","year":"2011","journal-title":"Mt Sinai J. Med"},{"issue":"3","key":"10.1016\/j.biopha.2025.118496_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/labinvest.3780235","article-title":"Multiple sclerosis: current pathophysiological concepts","volume":"81","author":"Wingerchuk","year":"2001","journal-title":"Lab. Investig."},{"issue":"1","key":"10.1016\/j.biopha.2025.118496_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.2011.02536.x","article-title":"Th17 cell, the new player of neuroinflammatory process in multiple sclerosis","volume":"74","author":"Jadidi-Niaragh","year":"2011","journal-title":"Scand. J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118496_bib27","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple sclerosis: mechanisms and immunotherapy","volume":"97","author":"Baecher-Allan","year":"2018","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.biopha.2025.118496_bib28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118496_bib29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nri2550","article-title":"Autoimmune t cell responses in the central nervous system","volume":"9","author":"Goverman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118496_bib30","doi-asserted-by":"crossref","first-page":"2035117","DOI":"10.1080\/21645515.2022.2035117","article-title":"Regulatory t cells (Tregs) and their therapeutic potential against autoimmune disorders\u2013Advances and challenges","volume":"18","author":"Goswami","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"issue":"6","key":"10.1016\/j.biopha.2025.118496_bib31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/md19060346","article-title":"Astaxanthin protects dendritic cells from lipopolysaccharide-induced immune dysfunction","volume":"19","author":"Yin","year":"2021","journal-title":"Mar. Drugs"},{"issue":"310","key":"10.1016\/j.biopha.2025.118496_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab4176","article-title":"Proinflammatory GM-CSF\u2013producing b cells in multiple sclerosis and b cell depletion therapy","volume":"7","author":"Li","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.biopha.2025.118496_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.biopha.2025.118496_bib34","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","article-title":"Role of the innate and adaptive immune responses in the course of multiple sclerosis","volume":"14","author":"Hemmer","year":"2015","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118496_bib35","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.3892\/etm.2017.4410","article-title":"Multiple sclerosis: pathology, diagnosis and treatments","volume":"13","author":"Huang","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.118496_bib36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ncl.2004.09.008","article-title":"Neuropathobiology of multiple sclerosis","volume":"23","author":"Peterson","year":"2005","journal-title":"Neurol. Clin."},{"issue":"14","key":"10.1016\/j.biopha.2025.118496_bib37","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3390\/cells12141872","article-title":"The gut\u2013brain axis as a therapeutic target in multiple sclerosis","volume":"12","author":"Buga","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.biopha.2025.118496_bib38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00204-023-03628-8","article-title":"Inflammation as common link to progressive neurological diseases","volume":"98","author":"Dias-Carvalho","year":"2024","journal-title":"Arch. Toxicol."},{"issue":"24","key":"10.1016\/j.biopha.2025.118496_bib39","doi-asserted-by":"crossref","first-page":"9357","DOI":"10.3390\/ijms21249357","article-title":"Thioredoxin-interacting protein (TXNIP) with focus on brain and neurodegenerative diseases","volume":"21","author":"Tsubaki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118496_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172973","article-title":"Targeting Keap1\/Nrf2\/ARE signaling pathway in multiple sclerosis","volume":"873","author":"Michali\u010dkov\u00e1","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118496_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.362","article-title":"An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis","volume":"5","author":"Garg","year":"2015","journal-title":"Brain Behav."},{"issue":"8","key":"10.1016\/j.biopha.2025.118496_bib42","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037297","article-title":"Review of multiple sclerosis: epidemiology, etiology, pathophysiology, and treatment","volume":"103","author":"Haki","year":"2024","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.biopha.2025.118496_bib43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118496_bib44","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118496_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1973834","article-title":"New insights into the role of oxidative stress mechanisms in the pathophysiology and treatment of multiple sclerosis","volume":"2016","author":"Adamczyk","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2025.118496_bib46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00415-004-0348-9","article-title":"The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy","volume":"251","author":"Gilgun-Sherki","year":"2004","journal-title":"J. Neurol."},{"key":"10.1016\/j.biopha.2025.118496_bib47","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s12035-014-9041-x","article-title":"Oxidative stress and neurobiology of demyelination","volume":"53","author":"Ljubisavljevic","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"172","key":"10.1016\/j.biopha.2025.118496_bib48","first-page":"121","article-title":"Effects of crocin on oxidative stress indices in rat brain demylated with ethidium bromide","volume":"29","author":"Fathi-Moghadam","year":"2019","journal-title":"J. Mazandaran Univ. Med. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118496_bib49","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ana.25197","article-title":"Inflammatory intrathecal profiles and cortical damage in multiple sclerosis","volume":"83","author":"Magliozzi","year":"2018","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118496_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11418-019-01364-x","article-title":"Carotenoids as natural functional pigments","volume":"74","author":"Maoka","year":"2020","journal-title":"J. Nat. Med"},{"key":"10.1016\/j.biopha.2025.118496_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2021.104969","article-title":"Crocins: a comprehensive review of structural characteristics, pharmacokinetics and therapeutic effects","volume":"153","author":"Song","year":"2021","journal-title":"Fitoterapia"},{"key":"10.1016\/j.biopha.2025.118496_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1009807","article-title":"Crocin: functional characteristics, extraction, food applications and efficacy against brain related disorders","volume":"9","author":"Ali","year":"2022","journal-title":"Front Nutr."},{"issue":"9","key":"10.1016\/j.biopha.2025.118496_bib53","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.4049\/jimmunol.1004111","article-title":"Neuroinflammation and endoplasmic reticulum stress are coregulated by crocin to prevent demyelination and neurodegeneration","volume":"187","author":"Deslauriers","year":"2011","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118496_bib54","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.4049\/jimmunol.1004111","article-title":"Neuroinflammation and endoplasmic reticulum stress are coregulated by crocin to prevent demyelination and neurodegeneration","volume":"187","author":"Deslauriers","year":"2011","journal-title":"Journal immunology (Baltimore Md 1950)"},{"key":"10.1016\/j.biopha.2025.118496_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10495-016-1296-4","article-title":"The role of endoplasmic reticulum stress in neurodegenerative disease","volume":"22","author":"Xiang","year":"2017","journal-title":"Apoptosis"},{"issue":"2","key":"10.1016\/j.biopha.2025.118496_bib56","first-page":"163","article-title":"P132: efficacy of crocin as Anti-Inflammatory agent in multiple sclerosis patients","volume":"6","author":"Habbibirad","year":"2018","journal-title":"Neurosci. J. Shefaye Khatam"},{"issue":"12","key":"10.1016\/j.biopha.2025.118496_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22410","article-title":"Effects of crocin in reducing DNA damage, inflammation, and oxidative stress in multiple sclerosis patients: a double-blind, randomized, and placebo-controlled trial","volume":"33","author":"Ghiasian","year":"2019","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118496_bib58","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00210-023-02424-6","article-title":"Protective effect of crocin on cuprizone-induced model of multiple sclerosis in mice","volume":"396","author":"Tashakori","year":"2023","journal-title":"NaunynSchmiede 's. Arch. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118496_bib59","doi-asserted-by":"crossref","DOI":"10.4103\/\/ANT.33-2_111_0093","article-title":"Effects of crocin on brain neurotrophins, cognition, balance and pain in Toxic-Induced demyelination model","volume":"33","author":"Fatemi","year":"2024","journal-title":"Acta Neurol. Taiwan."},{"key":"10.1016\/j.biopha.2025.118496_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105454","article-title":"Effects of crocin on inflammatory biomarkers and mental health status in patients with multiple sclerosis: a randomized, double-blinded clinical trial","volume":"83","author":"Kouchaki","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.biopha.2025.118496_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112328","article-title":"Potential health benefits of carotenoid lutein: an updated review","volume":"154","author":"Mitra","year":"2021","journal-title":"Food Chem. Toxicol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118496_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/nu10091321","article-title":"The effect of lutein on eye and Extra-Eye health","volume":"10","author":"Buscemi","year":"2018","journal-title":"Nutrients"},{"issue":"13","key":"10.1016\/j.biopha.2025.118496_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202300409","article-title":"Lutein and the underlying neuroprotective promise against neurodegenerative diseases","volume":"68","author":"Iyer","year":"2024","journal-title":"Mol. Nutr. Food Res"},{"issue":"8","key":"10.1016\/j.biopha.2025.118496_bib64","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.tjnut.2023.06.027","article-title":"Randomized, placebo-controlled, single-blind study of lutein supplementation on carotenoid status and cognition in persons with multiple sclerosis","volume":"153","author":"Martell","year":"2023","journal-title":"J. Nutr."},{"issue":"20","key":"10.1016\/j.biopha.2025.118496_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39253","article-title":"Lutein improves remyelination by reducing of neuroinflammation in C57BL\/6 mouse models of multiple sclerosis","volume":"10","author":"Arab Firozjae","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2025.118496_bib66","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/6252426","article-title":"Lycopene: a potent antioxidant with multiple health benefits","volume":"2024","author":"Shafe","year":"2024","journal-title":"J. Nutr. Metab."},{"key":"10.1016\/j.biopha.2025.118496_bib67","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/2713511","article-title":"Lycopene: food sources, biological activities, and human health benefits","volume":"2021","author":"Khan","year":"2021","journal-title":"Oxid. Med Cell Longev."},{"issue":"3","key":"10.1016\/j.biopha.2025.118496_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/nu10030325","article-title":"Fatty acids dietary supplements exert Anti-Inflammatory action and limit ganglion cell degeneration in the retina of the EAE mouse model of multiple sclerosis","volume":"10","author":"Dal Monte","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2025.118496_bib69","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3849692","article-title":"Astaxanthin: a potential Mitochondrial-Targeted antioxidant treatment in diseases and with aging","volume":"2019","author":"Sztretye","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2025.118496_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105479","article-title":"Therapeutic uses of natural astaxanthin: an evidence-based review focused on human clinical trials","volume":"166","author":"Donoso","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118496_bib71","first-page":"565","article-title":"Astaxanthin reduces demyelination and oligodendrocytes death in a rat model of multiple sclerosis","volume":"22","author":"Lotfi","year":"2021","journal-title":"Cell J."},{"issue":"3","key":"10.1016\/j.biopha.2025.118496_bib72","first-page":"160","article-title":"Astaxanthin effectiveness in preventing multiple sclerosis in animal model","volume":"119","author":"Bidaran","year":"2018","journal-title":"Bratisl. Lek. Listy"},{"issue":"3","key":"10.1016\/j.biopha.2025.118496_bib73","first-page":"279","article-title":"Study of the preventive and therapeutic effects of astaxanthin carotinoids on multiple sclerosis (MS) disease in C57BL\/6 mice","volume":"9","author":"Bidaran","year":"2018","journal-title":"Cell Tissue J."},{"issue":"2","key":"10.1016\/j.biopha.2025.118496_bib74","first-page":"69","article-title":"The evaluation of astaxanthin effects on differentiation of human adipose derived stem cells into oligodendrocyte precursor cells","volume":"10","author":"Ghasemi","year":"2018","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"10.1016\/j.biopha.2025.118496_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2023.105612","article-title":"The role of bixin as antioxidant, anti-inflammatory, anticancer, and skin protecting natural product extracted from bixa orellana l","volume":"169","author":"Ashraf","year":"2023","journal-title":"Fitoterapia"},{"key":"10.1016\/j.biopha.2025.118496_bib76","article-title":"Traditional uses, chemical constituents, and biological activities of bixa orellana L.: a review","volume":"2014","author":"Vilar Dde","year":"2014","journal-title":"TheScientificWorldJournal"},{"key":"10.1016\/j.biopha.2025.118496_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.593368","article-title":"Bixin attenuates experimental autoimmune encephalomyelitis by suppressing TXNIP\/NLRP3 inflammasome activity and activating NRF2 signaling","volume":"11","author":"Yu","year":"2020","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118496_bib78","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s11011-024-01349-0","article-title":"Anti-inflammatory, antioxidant and anti-mitophagy effects of trans sodium crocetinate on experimental autoimmune encephalomyelitis in BALB\/C57 mice","volume":"39","author":"Banaeeyeh","year":"2024","journal-title":"Metab. brain Dis."},{"issue":"3","key":"10.1016\/j.biopha.2025.118496_bib79","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/10284150290029205","article-title":"Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis","volume":"5","author":"Besler","year":"2002","journal-title":"Nutr. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118496_bib80","first-page":"27","article-title":"Association of Macro- and Micro-nutrients intake with the risk of multiple sclerosis: a case control study","volume":"1","author":"Behrooz","year":"2014","journal-title":"Nutr. Food Sci. Res."},{"issue":"2-3","key":"10.1016\/j.biopha.2025.118496_bib81","first-page":"72","article-title":"Nutrient patterns and risk of multiple sclerosis: a case-control study","volume":"4","author":"Akhoondan","year":"2014","journal-title":"J. Neurol. Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118496_bib82","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/antiox9030264","article-title":"The benefits and risks of certain dietary carotenoids that exhibit both anti-and pro-oxidative mechanisms\u2014A comprehensive review","volume":"9","author":"Black","year":"2020","journal-title":"Antioxidants"},{"issue":"20","key":"10.1016\/j.biopha.2025.118496_bib83","article-title":"Lutein improves remyelination by reducing of neuroinflammation in C57BL\/6 mouse models of multiple sclerosis","volume":"10","author":"Firozjae","year":"2024","journal-title":"Heliyon"},{"issue":"10","key":"10.1016\/j.biopha.2025.118496_bib84","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1016\/j.apsb.2023.07.010","article-title":"Oxidative stress, the blood\u2013brain barrier and neurodegenerative diseases: the critical beneficial role of dietary antioxidants","volume":"13","author":"Feng","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2025.118496_bib85","series-title":"Handbook of Food Bioactive Ingredients: Properties and Applications","first-page":"1","article-title":"Bixin: properties and applications","author":"Enayati","year":"2023"},{"issue":"9","key":"10.1016\/j.biopha.2025.118496_bib86","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/mnfr.201500109","article-title":"Lutein suppresses inflammatory responses through Nrf2 activation and NF-\u03baB inactivation in lipopolysaccharide-stimulated BV-2 microglia","volume":"59","author":"Wu","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"issue":"21","key":"10.1016\/j.biopha.2025.118496_bib87","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.3390\/nu15214652","article-title":"The antioxidant and anti-inflammatory effects of the main carotenoids from tomatoes via Nrf2 and NF-\u03baB signaling pathways","volume":"15","author":"Ba","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2025.118496_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.593368","article-title":"Bixin attenuates experimental autoimmune encephalomyelitis by suppressing TXNIP\/NLRP3 inflammasome activity and activating NRF2 signaling","volume":"11","author":"Yu","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118496_bib89","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","article-title":"Multiple sclerosis: an immune or neurodegenerative disorder?","volume":"31","author":"Trapp","year":"2008","journal-title":"Annu Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118496_bib90","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/molecules27020502","article-title":"Astaxanthin as a modulator of Nrf2, NF-\u03baB, and their crosstalk: molecular mechanisms and possible clinical applications","volume":"27","author":"Davinelli","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.biopha.2025.118496_bib91","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/08923973.2024.2445747","article-title":"Crocin as a potential therapeutic agent for multiple sclerosis: insights from experimental autoimmune encephalomyelitis model in mice","volume":"47","author":"Pazoki","year":"2025","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118496_bib92","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1134\/S0006297924100031","article-title":"Computational assessment of carotenoids as Keap1-Nrf2 Protein\u2013Protein interaction inhibitors: implications for antioxidant strategies","volume":"89","author":"Medoro","year":"2024","journal-title":"Biochemistry (Moscow)"},{"issue":"5","key":"10.1016\/j.biopha.2025.118496_bib93","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3892\/mi.2023.102","article-title":"Unleashing nature's potential and limitations: exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis","volume":"3","author":"Fathallah","year":"2023","journal-title":"Med. Int."},{"key":"10.1016\/j.biopha.2025.118496_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109601","article-title":"Activation of Nrf2 pathway as a protective mechanism against oxidative stress-induced diseases: potential of astaxanthin","volume":"741","author":"Kanwugu","year":"2023","journal-title":"Arch. Biochem. Biophys."},{"issue":"10","key":"10.1016\/j.biopha.2025.118496_bib95","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1007\/s00018-021-03802-0","article-title":"Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders","volume":"78","author":"Spaas","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.biopha.2025.118496_bib96","doi-asserted-by":"crossref","first-page":"1166S","DOI":"10.3945\/ajcn.112.034637","article-title":"Vitamin a and retinoic acid in t cell\u2013related immunity","volume":"96","author":"Ross","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.biopha.2025.118496_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2022.12816","article-title":"Biological and neurological activities of astaxanthin","volume":"26","author":"Si","year":"2022","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118496_bib98","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13024-024-00742-8","article-title":"The interplay of inflammation and remyelination: rethinking MS treatment with a focus on oligodendrocyte progenitor cells","volume":"19","author":"Zveik","year":"2024","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.biopha.2025.118496_bib99","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nn.2702","article-title":"Retinoid x receptor gamma signaling accelerates CNS remyelination","volume":"14","author":"Huang","year":"2011","journal-title":"Nat. Neurosci."},{"issue":"16","key":"10.1016\/j.biopha.2025.118496_bib100","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1523\/JNEUROSCI.2922-18.2019","article-title":"Regulation of myelination by exosome associated retinoic acid release from NG2-positive cells","volume":"39","author":"Goncalves","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2025.118496_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119653","article-title":"Retinoic acid-loaded NFL-lipid nanocapsules promote oligodendrogenesis in focal White matter lesion","volume":"230","author":"Carradori","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.118496_bib102","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jconrel.2023.04.034","article-title":"Functionalized retinoic acid lipid nanocapsules promotes a two-front attack on inflammation and lack of demyelination on neurodegenerative disorders","volume":"358","author":"Moura","year":"2023","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.biopha.2025.118496_bib103","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.advnut.2022.10.007","article-title":"Carotenoids and their health benefits as derived via their interactions with gut microbiota","volume":"14","author":"Eroglu","year":"2023","journal-title":"Adv. Nutr."},{"issue":"16","key":"10.1016\/j.biopha.2025.118496_bib104","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.3390\/ijms25168921","article-title":"A comprehensive examination of the role of epigenetic factors in multiple sclerosis","volume":"25","author":"Manna","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118496_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40246-018-0163-5","article-title":"The tale of histone modifications and its role in multiple sclerosis","volume":"12","author":"He","year":"2018","journal-title":"Hum. Genom."},{"key":"10.1016\/j.biopha.2025.118496_bib106","doi-asserted-by":"crossref","first-page":"1281567","DOI":"10.3389\/fimmu.2023.1281567","article-title":"The role of microRNAs involved in the disorder of blood\u2013brain barrier in the pathogenesis of multiple sclerosis","volume":"14","author":"Emami Nejad","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"10.1016\/j.biopha.2025.118496_bib107","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2010.09.009","article-title":"MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development","volume":"33","author":"O\u2019Connell","year":"2010","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.biopha.2025.118496_bib108","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/ni.1798","article-title":"MicroRNA miR-326 regulates Th-17 differentiation and is associated with the pathogenesis of multiple sclerosis","volume":"10","author":"Du","year":"2009","journal-title":"Nature Immunology"},{"issue":"9","key":"10.1016\/j.biopha.2025.118496_bib109","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/antiox10091448","article-title":"Lutein as a modulator of oxidative stress-mediated inflammatory diseases","volume":"10","author":"Ahn","year":"2021","journal-title":"Antioxidants"},{"issue":"8","key":"10.1016\/j.biopha.2025.118496_bib110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3390\/md16080247","article-title":"On the neuroprotective role of astaxanthin: new perspectives?","volume":"16","author":"Galasso","year":"2018","journal-title":"Mar. Drugs"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225006900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225006900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T02:50:01Z","timestamp":1760583001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225006900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":110,"alternative-id":["S0753332225006900"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118496","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carotenoids as neuroprotective agents in multiple sclerosis: Pathways, mechanisms, and clinical prospects","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118496"}}